Cite
Cremolini C, Pietrantonio F, Tomasello G, et al. Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study. ESMO Open. 2017;2(3):e000241doi: 10.1136/esmoopen-2017-000241.
Cremolini, C., Pietrantonio, F., Tomasello, G., Dadduzio, V., Moretto, R., Morano, F., Schirripa, M., Antoniotti, C., Fucà, G., Bergamo, F., Rossini, D., Nichetti, F., Ziampiri, S., Ghidini, M., Marmorino, F., Prisciandaro, M., Falcone, A., De Braud, F., Loupakis, F., & Lonardi, S. (2017). Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study. ESMO open, 2(3), e000241. https://doi.org/10.1136/esmoopen-2017-000241
Cremolini, Chiara, et al. "Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study." ESMO open vol. 2,3 (2017): e000241. doi: https://doi.org/10.1136/esmoopen-2017-000241
Cremolini C, Pietrantonio F, Tomasello G, Dadduzio V, Moretto R, Morano F, Schirripa M, Antoniotti C, Fucà G, Bergamo F, Rossini D, Nichetti F, Ziampiri S, Ghidini M, Marmorino F, Prisciandaro M, Falcone A, De Braud F, Loupakis F, Lonardi S. Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study. ESMO Open. 2017 Aug 10;2(3):e000241. doi: 10.1136/esmoopen-2017-000241. eCollection 2017. PMID: 29209533; PMCID: PMC5703381.
Copy
Download .nbib